{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:09 23:24:50.411",
            "Expression": "NCT03197623",
            "NStudiesAvail": 430269,
            "NStudiesFound": 1,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 1,
            "FieldList": [
                  "BriefSummary",
                  "BriefTitle",
                  "CentralContactEMail",
                  "CentralContactName",
                  "CentralContactPhone",
                  "CentralContactPhoneExt",
                  "CentralContactRole",
                  "CollaboratorClass",
                  "CollaboratorName",
                  "CompletionDate",
                  "CompletionDateType",
                  "Condition",
                  "ConditionAncestorId",
                  "ConditionAncestorTerm",
                  "ConditionBrowseBranchAbbrev",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "BriefSummary": [
                              "A Phase 1 Randomized, Double-Blind, Placebo-Controlled Single and Multiple Ascending Dose Study of the Safety and Tolerability of Intravenous LLP2A-Alendronate in Adult Men and Women with Osteopenia Secondary to Corticosteroids"
                        ],
                        "BriefTitle": [
                              "Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [
                              "OTHER"
                        ],
                        "CollaboratorName": [
                              "California Institute for Regenerative Medicine (CIRM)"
                        ],
                        "CompletionDate": [
                              "March 31, 2021"
                        ],
                        "CompletionDateType": [
                              "Actual"
                        ],
                        "Condition": [
                              "Osteopenia",
                              "Osteoporosis",
                              "Osteonecrosis"
                        ],
                        "ConditionAncestorId": [
                              "D000001847",
                              "D000009140",
                              "D000008659",
                              "D000009336",
                              "D000010335"
                        ],
                        "ConditionAncestorTerm": [
                              "Bone Diseases",
                              "Musculoskeletal Diseases",
                              "Metabolic Diseases",
                              "Necrosis",
                              "Pathologic Processes"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC04",
                              "BC23",
                              "All",
                              "BC05",
                              "BC18"
                        ],
                        "NCTId": [
                              "NCT03197623"
                        ]
                  }
            ]
      }
}